GLP-3 (Reta) also known as Retatrutide is an advanced next-generation metabolic peptide engineered to target three key hormone receptors: GLP-1, GIP, and glucagon (GCGR). This triple-agonist mechanism is designed to support broader metabolic activity compared to earlier single- or dual-pathway compounds, making it a highly researched peptide in the metabolic science space.
Retatrutide is supplied as a lyophilized (freeze-dried) powder, ensuring stability during storage and precise handling. Each batch is produced and handled under controlled conditions to maintain structural integrity and consistency across all vials.
